The global cannabidiol market size is expected to reach USD 22.05 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2025 ...

Experts are sounding the alarm about increased use of kratom and about highly concentrated products containing 7-OH, a more ...

SAN FRANCISCO, May 13, 2025 /PRNewswire/ -- The global cannabidiol market size is expected ... to produce personal care products and medical drugs. Legalizing cannabis-based products has opened ...

Cannabis smoking and tobacco smoking appear to have disparate impacts on lung health, according to data published in the ...

New research published in Psychopharmacology shows that cannabidiol, a major non-psychoactive compound in cannabis, can ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss the Supreme Court's decision as to the type of ...

BRC Therapeutics (BRC), a pharmaceutical company developing proprietary cannabinoid therapeutics, announced today that Dr.

IHL-42X is designed to treat obstructive sleep apnea ("OSA”) by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, ...

Reform of roadside drug tests to legally protect patients using medicinal cannabis is being pushed by Australia’s medicinal ...

SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...